| Home | FAQs | Support | WebAudit | Audit Codes | Download Files | View Instructions | Standards of Care | Past Results | Get Epi Info |
| The
Unofficial IHS Diabetes Care & Outcomes Audit Support Site |
![]() |
||
|
Hosted by Ray Shields, MD |
|||
| Part 2: Supporting Statements | |||
| 5. Other Topics for Consideration | |||
| a. Distinguishing Type 1 and Type 2 Diabetes | |||
|
Although no test can
definitively distinguish type 1 from type 2, several laboratory studies
may be helpful when the diagnosis
is not clear clinically. Providers
should consider obtaining consultation if they are unfamiliar with the use of these tests or how to make a diagnosis in a
complex patient. Incorrectly
diagnosing type 2 diabetes in a patient who truly has type 1 can cause
considerable problems. Measurement of endogenous insulin secretion
The results for these tests may be low in type 2
patients with glucose toxicity. If in doubt, measure after glycemic control
has been restored for several weeks: ·
Fasting Insulin Level — if
the patient is not on exogenous insulin. ·
C-peptide, the other half of
pro-insulin. This test is useful even if the patient is taking insulin injections. Autoantibodies Positive antibody tests denote an
autoimmune process, but negative tests do not rule it out: ·
Islet cell antibodies (ICA) ·
Glutamic acid decarboxylate
antibodies (GADA) ·
Other antibody tests have
been used in research and some clinical settings (e.g. thyroid peroxidase
antibodies, insulin autoantibodies, etc). Other lab tests and exams Gauging
the degree of insulin deficiency versus insulin resistance
with the following tests can be helpful.
Although some overweight type 1 patients may have some signs of
insulin resistance, in general, they will not have the usual type 2
diabetes measurements at diagnosis: ·
Lipids: Type 2
diabetes patients
have the typical low HDL/high triglyceride pattern ·
Blood pressure: Type 2
patients often have some degree of hypertension at diabetes diagnosis ·
Ketones: Although patients
with type 2 can have ketonuria and even diabetic ketoacidosis (DKA), generally
these only occur at
very high glucose levels or with a serious concurrent illness or
infection. More often, it is
patients with type 1 who have significant ketonuria and who are more
profoundly acidotic with DKA. ·
Microvascular complications:
Many type 2 patients already have retinopathy, microproteinuria, or
neuropathy at the time of diagnosis, whereas this is almost never true of
patients with type 1 diabetes. ·
Weight loss: The degree
and speed of weight loss before diagnosis is usually more rapid in
patients with type 1 than type 2 diabetes.
|
| Home | SOC Contents | << Previous | Next >> |